Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38377
CAS Number:
80621-81-4
Rifaximin
Purity:
≥ 97% (HPLC)
Documents
$144.12 /1G
Pack Size Availability Price
Request Bulk Quote
Product Information

Rifaximin is a broad-spectrum antibiotic that is primarily used for the treatment of gastrointestinal infections, particularly those caused by non-invasive strains of Escherichia coli. Its unique mechanism of action, which involves inhibiting bacterial RNA synthesis, makes it effective against a variety of Gram-positive and Gram-negative bacteria. Rifaximin is particularly notable for its low systemic absorption, allowing it to act locally in the gut while minimizing potential side effects. This characteristic makes it an excellent choice for treating conditions such as traveler's diarrhea and irritable bowel syndrome with diarrhea (IBS-D).

In addition to its gastrointestinal applications, Rifaximin has shown promise in treating hepatic encephalopathy, helping to reduce the risk of recurrence in patients with liver disease. Its versatility and efficacy in various therapeutic areas highlight its importance in modern medicine. Researchers and healthcare professionals appreciate Rifaximin for its targeted action and favorable safety profile, making it a valuable tool in both clinical and research settings.

CAS Number
80621-81-4
Purity
≥ 97% (HPLC)
Molecular Formula
C43H51N3O11
Molecular Weight
785.89
MDL Number
MFCD00864973
PubChem ID
53395233
Melting Point
212 °C
Appearance
Orange to brown powder to crystal
Conditions
Store at 2 - 8 °C
General Information
CAS Number
80621-81-4
Purity
≥ 97% (HPLC)
Molecular Formula
C43H51N3O11
Molecular Weight
785.89
MDL Number
MFCD00864973
PubChem ID
53395233
Melting Point
212 °C
Appearance
Orange to brown powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Rifaximin is widely utilized in research focused on:

  • Antibiotic Treatment: Primarily used to treat gastrointestinal infections, Rifaximin is effective against certain strains of bacteria, making it a go-to option for conditions like traveler's diarrhea and irritable bowel syndrome.
  • Hepatic Encephalopathy Management: This compound helps reduce the risk of hepatic encephalopathy in patients with liver disease by decreasing the production of ammonia in the gut, thus improving overall patient outcomes.
  • Research in Gut Microbiome: Rifaximin is employed in studies examining the gut microbiome's role in health and disease, providing insights into how antibiotics can modulate gut flora and impact metabolic conditions.
  • Pharmaceutical Development: Its unique properties make Rifaximin a subject of interest in developing new formulations and delivery systems, enhancing the effectiveness of treatments for gastrointestinal disorders.
  • Cost-Effective Treatment Option: Compared to other antibiotics, Rifaximin often presents a lower risk of developing resistance, making it a more sustainable choice for long-term treatment regimens.

Citations